Berberine as a promising safe anti-cancer agent - is there a role for mitochondria?
暂无分享,去创建一个
P. Oliveira | Teresa L. Serafim | C. Diogo | A. Burgeiro | N. G. Machado | Teresa Serafim | I. Barbosa
[1] S. Tsao,et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: The cellular mechanism , 2010, Journal of cellular biochemistry.
[2] Jinhe Kim,et al. Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. , 2010, European journal of pharmacology.
[3] M. Kheir,et al. Acute toxicity of berberine and its correlation with the blood concentration in mice. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[4] Lisa M. Miller,et al. Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters. , 2010, Atherosclerosis.
[5] A. Dhir,et al. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders , 2010, Phytotherapy research : PTR.
[6] J. Hoheisel,et al. Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours. , 2010, Current drug discovery technologies.
[7] Sten Orrenius,et al. The Warburg effect and mitochondrial stability in cancer cells. , 2010, Molecular aspects of medicine.
[8] G. Scambia,et al. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. , 2009, Biochemical pharmacology.
[9] Yung-Hyun Choi,et al. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. , 2009, Anticancer research.
[10] Y. Tong,et al. Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. , 2009, International journal of molecular medicine.
[11] B Xie,et al. Synergistic therapeutic actions of herbal ingredients and their mechanisms from molecular interaction and network perspectives. , 2009, Drug discovery today.
[12] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[13] Chun Guo,et al. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. , 2009, Mutation research.
[14] P. Clarke,et al. Cell-cycle control in the face of damage--a matter of life or death. , 2009, Trends in cell biology.
[15] K. Jung,et al. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.
[16] B. Zhivotovsky,et al. Mitochondria as targets for chemotherapy , 2009, Apoptosis.
[17] S. Katiyar,et al. p53 cooperates berberine‐induced growth inhibition and apoptosis of non‐small cell human lung cancer cells in vitro and tumor xenograft growth in vivo , 2009, Molecular carcinogenesis.
[18] P. Oliveira,et al. Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells--nuclear vs. mitochondrial effects. , 2008, Biochemical pharmacology.
[19] Wei-Jia Kong,et al. Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[20] P. Oliveira,et al. Mechanisms of berberine (natural yellow 18)-induced mitochondrial dysfunction: interaction with the adenine nucleotide translocator. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[21] J. Mackey,et al. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer , 2008, British Journal of Cancer.
[22] V. Shoshan-Barmatz,et al. Methyl jasmonate binds to and detaches mitochondria-bound hexokinase , 2008, Oncogene.
[23] H. Hosseinzadeh,et al. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine , 2008, Phytotherapy research : PTR.
[24] Wei-Jia Kong,et al. Combination of simvastatin with berberine improves the lipid-lowering efficacy. , 2008, Metabolism: clinical and experimental.
[25] Yung-Hyun Choi,et al. Sanguinarine, a Benzophenanthridine Alkaloid, Induces Apoptosis in MDA-MB-231 Human Breast Carcinoma Cells through a Reactive Oxygen Species-Mediated Mitochondrial Pathway , 2008, Chemotherapy.
[26] G. Ning,et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. , 2008, The Journal of clinical endocrinology and metabolism.
[27] B. Aggarwal,et al. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. , 2008, Cancer research.
[28] Y. Yoo,et al. Sanguinarine-Induced Apoptosis in Human Leukemia U937 Cells via Bcl-2 Downregulation and Caspase-3 Activation , 2008, Chemotherapy.
[29] Jianping Ye,et al. Efficacy of berberine in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.
[30] P. Oliveira,et al. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line , 2008, Cancer Chemotherapy and Pharmacology.
[31] R. Park,et al. Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway. , 2008, Biological & pharmaceutical bulletin.
[32] R. Stoika,et al. A decisive role of mitochondria in defining rate and intensity of apoptosis induction by different alkaloids. , 2008, Toxicology letters.
[33] M. Butterworth,et al. A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells , 2008, Cell Death and Differentiation.
[34] Seung Joon Baek,et al. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. , 2007, Cancer letters.
[35] P. Oliveira,et al. Mitochondrially Targeted Effects of Berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 Mouse Melanoma Cells: Comparison with Direct Effects on Isolated Mitochondrial Fractions , 2007, Journal of Pharmacology and Experimental Therapeutics.
[36] Hui-Ju Lin,et al. GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. , 2007, Anticancer research.
[37] Shun-Fa Yang,et al. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL , 2007, Archives of Toxicology.
[38] M. López-Lázaro. Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved , 2007, Expert opinion on therapeutic targets.
[39] Peng Huang,et al. The Warburg effect and its cancer therapeutic implications , 2007, Journal of bioenergetics and biomembranes.
[40] L. Platanias,et al. Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. , 2007, Cancer research.
[41] Xiu-fang Wang,et al. Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II , 2007, Journal of bioenergetics and biomembranes.
[42] L. Cipak,et al. Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.
[43] W. Sadee,et al. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia , 2007, Cancer Chemotherapy and Pharmacology.
[44] H. Nakamura,et al. Tumor-targeted induction of oxystress for cancer therapy , 2007, Journal of drug targeting.
[45] Peng Huang,et al. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism , 2006, The Journal of cell biology.
[46] R. Youle,et al. How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane? , 2006, Current opinion in cell biology.
[47] L. Yao,et al. Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9 , 2006, Applied biochemistry and biotechnology.
[48] R. Dhir,et al. Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. , 2006, Carcinogenesis.
[49] C. Scott,et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. , 2006, Cancer cell.
[50] H. Pehamberger,et al. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] S. Katiyar,et al. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. , 2006, Carcinogenesis.
[52] D. Albert,et al. Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells. , 2006, Investigative ophthalmology & visual science.
[53] Jinsong Liu,et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.
[54] S. Zunino,et al. Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. , 2006, Cancer letters.
[55] N. Hay,et al. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt , 2006, Oncogene.
[56] G. Kroemer,et al. Mitochondria in cancer , 2006, Oncogene.
[57] D. James,et al. Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States , 2006, Diabetes.
[58] Yan Zhao,et al. Vitamin E analogues as anticancer agents: Lessons from studies with α‐tocopheryl succinate , 2006 .
[59] Y. Hsieh,et al. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. , 2006, Toxicology and applied pharmacology.
[60] P. Leder,et al. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.
[61] V. Shoshan-Barmatz,et al. The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. , 2006, Current pharmaceutical design.
[62] P. Oliveira,et al. Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats--relevance for mitochondrial dysfunction. , 2006, Toxicology.
[63] C. Ting,et al. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. , 2006, Biochemical pharmacology.
[64] S. Katiyar,et al. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells , 2006, Molecular Cancer Therapeutics.
[65] S. Letašiová,et al. Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells , 2006, The Journal of pharmacy and pharmacology.
[66] J. Y. Liu,et al. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells , 2006, Archives of Toxicology.
[67] T. Schulz,et al. Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth , 2006, Journal of Biological Chemistry.
[68] Jai-Sing Yang,et al. Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. , 2006, World journal of gastroenterology.
[69] Y. Jang,et al. Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. , 2005, Molecules and cells.
[70] M. Gleave,et al. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells , 2005, Molecular Cancer Therapeutics.
[71] J. Gledhill,et al. Inhibition sites in F1-ATPase from bovine heart mitochondria. , 2005, The Biochemical journal.
[72] A. Gosslau,et al. A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts , 2005, British Journal of Cancer.
[73] Peng Huang,et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. , 2005, Cancer research.
[74] D. Hockenbery,et al. Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. , 2004, Biochimica et biophysica acta.
[75] Satoru Inaba,et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins , 2004, Nature Medicine.
[76] Hans-Dieter Höltje,et al. Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model , 2004, J. Comput. Aided Mol. Des..
[77] J. Modica-Napolitano,et al. Mitochondrial dysfunction in cancer. , 2004, Mitochondrion.
[78] V. Kettmann,et al. In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines. , 2004, Die Pharmazie.
[79] Peng Huang,et al. ROS stress in cancer cells and therapeutic implications. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[80] Herbert Schneckenburger,et al. Fluorescence lifetime imaging (FLIM) of rhodamine 123 in living cells , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[81] J. Arrabaça,et al. Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. , 2003, Toxicology letters.
[82] L. Cipak,et al. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells , 2003, The Journal of pharmacy and pharmacology.
[83] B. G. Sanders,et al. RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. , 2003, Cancer research.
[84] J. Folkman,et al. A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. , 2003, Cancer cell.
[85] A. Halestrap,et al. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. , 2002, The Biochemical journal.
[86] J. P. Fawcett,et al. The involvement of P-glycoprotein in berberine absorption. , 2002, Pharmacology & toxicology.
[87] Luca Scorrano,et al. A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. , 2002, Cancer cell.
[88] V. Gogvadze,et al. Fas‐triggered phosphatidylserine exposure is modulated by intracellular ATP , 2002, FEBS letters.
[89] J. Hoek,et al. Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis* , 2002, The Journal of Biological Chemistry.
[90] M. Madesh,et al. VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release , 2001, The Journal of cell biology.
[91] J. Modica-Napolitano,et al. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. , 2001, Advanced drug delivery reviews.
[92] A. Terpstra. Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate. , 2001, The Journal of nutrition.
[93] R. Greil,et al. Resveratrol, a tumor‐suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl‐2 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[94] D. Voehringer,et al. Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[95] X. Yao,et al. Vasorelaxant and antiproliferative effects of berberine. , 2000, European journal of pharmacology.
[96] G. Kroemer,et al. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis , 2000, Oncogene.
[97] R. Laucirica,et al. Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model , 1999, Oncogene.
[98] H. Wu,et al. Berberine‐induced apoptosis of human leukemia HL‐60 cells is associated with down‐regulation of nucleophosmin/B23 and telomerase activity , 1999, International journal of cancer.
[99] D. V. Von Hoff,et al. Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units. , 1999, Anti-cancer drugs.
[100] T. Maeda,et al. K‐252a‐induced polyploidization and differentiation of a human megakaryocytic cell line, Meg‐J: transient elevation and subsequent suppression of cyclin B1 and cdc2 expression in the process of polyploidization , 1998, British journal of haematology.
[101] A. Strasser,et al. The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry. , 1996, The EMBO journal.
[102] Shishido,et al. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. , 1996, Cancer research.
[103] J. Modica-Napolitano,et al. Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. , 1996, Cancer research.
[104] Ni Yx. Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research , 1988 .
[105] R. Salem,et al. Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[106] T. Lampidis,et al. Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye. , 1983, Science.
[107] V. Mikes,et al. Berberine derivatives as cationic fluorescent probes for the investigation of the energized state of mitochondria. , 1983, Biochimica et biophysica acta.
[108] I. Summerhayes,et al. Selective toxicity of rhodamine 123 in carcinoma cells in vitro. , 1983, Cancer research.
[109] I. Summerhayes,et al. Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. , 1982, Science.
[110] I. Summerhayes,et al. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[111] A. Zelenin,et al. [Fluorescence microscopy demonstration of mitochondria in tissue culture cells using berberine]. , 1977, Tsitologiia.
[112] T. Subbaiah,et al. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. , 1969, Canadian journal of microbiology.
[113] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[114] Jianping Ye,et al. Berberine improves glucose metabolism through induction of glycolysis. , 2008, American journal of physiology. Endocrinology and metabolism.
[115] Jing-Gung Chung,et al. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. , 2006, Anticancer research.
[116] B. Baysal. Role of mitochondrial mutations in cancer , 2006, Endocrine pathology.
[117] C. Chi,et al. Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. , 2005, In vivo.
[118] M. D. Faddeeva,et al. [Inhibition of liver mitochondrial monoamine oxidase activity by alkaloids isolated from Chelidonium and Macleaya and by their derivative drugs]. , 2003, Tsitologiia.
[119] Da-yuan Zhu,et al. Identification of three sulfate-conjugated metabolites of berberine chloride in healthy volunteers' urine after oral administration. , 2002, Acta pharmacologica Sinica.
[120] S. Korsmeyer,et al. Bax accelerates tumorigenesis in p53-deficient mice. , 2001, Cancer research.
[121] H. Kerl,et al. Effect of dequalinium on K1735-M2 melanoma cell growth, directional migration and invasion in vitro. , 1992, European journal of cancer.